Inventor · disambiguated record
Ross A. Miller
Also filed as: MILLER ROSS A
17 granted patents·8 pending applications·106 citations·filing 1994–2024
92Inventor score
Top patents by PatentIndex Score
25 records- 0191US9944622B2Pyrimidinyl tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Apr 17, 2018·8 cites·16 claims
- 0291US9353087B2Inhibitors of Bruton's tyrosine kinaseBIOGEN IDEC INC·Filed 2013·Granted May 31, 2016·8 cites·19 claims
- 0389US9394277B2Pyrimidinyl tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2013·Granted Jul 19, 2016·11 cites·26 claims
- 0484US10618887B2Pyrimidinyl tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Granted Apr 14, 2020·3 cites·17 claims
- 0583US2024417389A1Pyrimidinyl tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0677US6369247B1Process for oxidation of steroidal compounds having allylic groupsMERCK & CO INC·Filed 1995·Granted Apr 9, 2002·31 cites·25 claims
- 0777US2023174511A1Pyrimidinyl tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0873US7863307B2Process for synthesizing a CETP inhibitorMERCK SHARP & DOHME·Filed 2006·Granted Jan 4, 2011·2 cites·24 claims
- 0971US8686141B2Process for preparing N-substituted hydroxypyrimidinone carboxamidesHUMPHREY GUY R·Filed 2008·Granted Apr 1, 2014·3 cites·27 claims
- 1068US2021017155A1Pyrimidinyl tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1165US5696266AProcess for the stereoselective reduction of steroid enelactamsMERCK & CO INC·Filed 1995·Granted Dec 9, 1997·16 cites·15 claims
- 1265US5470976AProcess for the stereoselective reduction of steroid enelactamsMERCK & CO INC·Filed 1994·Granted Nov 28, 1995·12 cites·18 claims
- 1363US10189817B2Inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Jan 29, 2019·0 cites·6 claims
- 1458US5817802AProcess for the stereoselective reduction of steroid enelactamsMERCK & CO INC·Filed 1997·Granted Oct 6, 1998·10 cites·14 claims
- 1554US2017114039A1Inhibitors of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 1640US10370403B2Methods for the synthesis of cerageninsSAVAGE PAUL B·Filed 2016·Granted Aug 6, 2019·0 cites·27 claims
- 1740US2003191121A1Piperazine carboxamide intermediates of HIV protease inhibitors and processes for their preparationFiled 2002·Application pending·0 cites
- 1838US2007225499A1Process for the Preparation of 2,2-Disubstituted PyrrolesJAVADI GARY·Filed 2005·Application pending·0 cites
- 1938US2017174720A9Cationic steroidal antimicrobial saltsSAVAGE PAUL B·Filed 2016·Application pending·0 cites
- 2037US2004147787A1Process for oxidation of alcoholsFiled 2001·Application pending·0 cites
- 2135US6187925B1Intermediates and process for the synthesis of azasteroidsMERCK & CO INC·Filed 1998·Granted Feb 13, 2001·1 cites·15 claims
- 2231US6489471B1Process for the synthesis of carbapenem intermediates, and compounds producedMERCK & CO INC·Filed 1999·Granted Dec 3, 2002·0 cites·27 claims
- 2328US5908936AProcess for synthesizing carbapenem intermediatesMERCK & CO INC·Filed 1998·Granted Jun 1, 1999·0 cites·19 claims
- 2425US6252063B1Crystalline salts of a carbapenem antibioticMERCK & CO INC·Filed 1999·Granted Jun 26, 2001·0 cites·6 claims
- 2524US5585383AProcess for crystallizing a 4-azasteroid 5alpha-reductase inhibitorMERCK & CO INC·Filed 1995·Granted Dec 17, 1996·1 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Ross A. Miller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →